Related Experiment Videos

Effect of three lipophilic methotrexate derivatives upon mediator release by lipopolysaccharide-stimulated rat

A S Williams1, N Topley, N Amos

  • 1Rheumatology Research Laboratory, University of Wales College of Medicine, Heath Park, Cardiff, UK.

Insights

Lipophilic methotrexate derivatives effectively inhibited tumor necrosis factor (TNF) and prostaglandin E2 (PGE2) release from stimulated macrophages. Methotrexate-gamma-dimyristoylphosphatidylethanolamine (M gamma D) showed potent inhibition, while M alpha D and M alpha gamma D also demonstrated significant effects.

Area of Science:

  • Immunology
  • Pharmacology
  • Cell Biology

Background:

  • Macrophages play a crucial role in inflammatory responses.
  • Lipopolysaccharide (LPS) is a potent stimulator of macrophage activation.
  • Tumor necrosis factor (TNF) and prostaglandin E2 (PGE2) are key inflammatory mediators released by macrophages.

Purpose of the Study:

  • To investigate the immunomodulatory effects of methotrexate and its lipophilic derivatives on mediator release from LPS-stimulated rat peritoneal macrophages.
  • To compare the inhibitory potential of different methotrexate conjugates on TNF and PGE2 production.

Main Methods:

  • Rat peritoneal macrophages were stimulated with lipopolysaccharide (LPS).
  • The release of TNF and PGE2 was measured in the presence of varying concentrations of methotrexate and its lipophilic derivatives: M gamma D, M alpha D, and M alpha gamma D.
  • Cellular ATP levels were assessed to evaluate cytotoxicity.

Main Results:

  • Lipophilic methotrexate derivatives, particularly M gamma D and M alpha D, significantly inhibited TNF release at nontoxic concentrations.
  • All three methotrexate conjugates potently inhibited PGE2 production in a dose-dependent manner.
  • M alpha gamma D showed reduced efficacy in inhibiting PGE2 at lower concentrations and significantly impacted cellular ATP levels.
  • Unconjugated methotrexate did not inhibit TNF or PGE2 release.

Conclusions:

  • Lipophilic modification of methotrexate enhances its ability to inhibit inflammatory mediator release from macrophages.
  • Methotrexate derivatives, especially M gamma D, show promise as modulators of macrophage-mediated inflammation.
  • The efficacy and potential toxicity of methotrexate derivatives are dependent on their lipophilic structure and concentration.

Related Concept Videos